These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9696487)

  • 1. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.
    Pol S; Fontaine H; Carnot F; Zylberberg H; Berthelot P; Bréchot C; Nalpas B
    J Hepatol; 1998 Jul; 29(1):12-9. PubMed ID: 9696487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.
    Rostaing L; Izopet J; Cisterne JM; Arnaud C; Duffaut M; Rumeau JL; Puel J; Durand D
    Transplantation; 1998 Apr; 65(7):930-6. PubMed ID: 9565097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].
    Kryczka W; Chrapek M; Paluch K; Zarebska-Michaluk D; Urbaniak A
    Pol Arch Med Wewn; 2003 Aug; 110(2):869-75. PubMed ID: 14682226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical forms and prognosis of hepatitis C].
    Pol S; Zylberberg H
    Rev Prat; 2000 May; 50(10):1083-8. PubMed ID: 10905093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological features of chronic hepatitis C in haemodialysis patients.
    Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I
    Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study.
    Serfaty L; Chazouillères O; Poujol-Robert A; Morand-Joubert L; Dubois C; Chrétien Y; Poupon RE; Petit JC; Poupon R
    Hepatology; 1997 Sep; 26(3):776-9. PubMed ID: 9303512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.
    Garvey P; Murphy N; Flanagan P; Brennan A; Courtney G; Crosbie O; Crowe J; Hegarty J; Lee J; McIver M; McNulty C; Murray F; Nolan N; O'Farrelly C; Stewart S; Tait M; Norris S; Thornton L
    J Hepatol; 2017 Dec; 67(6):1140-1147. PubMed ID: 28843656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological features of hepatitis C in renal transplant candidates [see comment].
    Martin P; Carter D; Fabrizi F; Dixit V; Conrad AJ; Artinian L; Peacock V; Han S; Wilkinson A; Lassman CR; Danovitch G
    Transplantation; 2000 Apr; 69(7):1479-84. PubMed ID: 10798774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus.
    Roudot-Thoraval F; Bastie A; Pawlotsky JM; Dhumeaux D
    Hepatology; 1997 Aug; 26(2):485-90. PubMed ID: 9252163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
    Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
    J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood.
    Macías J; Sánchez-Quijano A; Pineda JA; Abad MA; Rubio A; Rosa R; Leal M; Lissen E
    Liver; 2001 Dec; 21(6):410-4. PubMed ID: 11903886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels.
    Renou C; Halfon P; Pol S; Cacoub P; Jouve E; Bronowicki JP; Arpurt JP; Rifflet H; Picon M; Causse X; Canva V; Denis J; Tran A; Bourliére M; Ouzan D; Pariente A; Dantin S; Alric L; Cartier V; Reville M; Caillat-Zucman S
    Gut; 2002 Oct; 51(4):585-90. PubMed ID: 12235085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting progression to cirrhosis in chronic hepatitis C virus infection.
    Freeman AJ; Law MG; Kaldor JM; Dore GJ
    J Viral Hepat; 2003 Jul; 10(4):285-93. PubMed ID: 12823595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis.
    Soto B; Sánchez-Quijano A; Rodrigo L; del Olmo JA; García-Bengoechea M; Hernández-Quero J; Rey C; Abad MA; Rodríguez M; Sales Gilabert M; González F; Mirón P; Caruz A; Relimpio F; Torronteras R; Leal M; Lissen E
    J Hepatol; 1997 Jan; 26(1):1-5. PubMed ID: 9147999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.